ERBB2 and colorectal carcinoma: FISH for HER2 could play a complementary role in the detection of oncogene amplification in HM and could be used to select targeted therapy in patients who progress to postmolar GTN, as is the case for breast and colorectal carcinoma and other malignant neoplasms.15